We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Blue-Green Algae Evaluated for Treating Amyotrophic Lateral Sclerosis

By LabMedica International staff writers
Posted on 20 Jan 2011
Nutritional supplements containing Spirulina, a nutrient-rich, blue-green algae, was shown to provide neuroprotective support for dying motor neurons in a mouse model of amyotrophic lateral sclerosis (ALS). More...
Although more research is needed, the neuroscientists involved in the study suggest that a Spirulina-supplemented diet may provide clinical benefits for ALS patients.

A Spirulina dietary supplement was revealed to delay the onset of motor symptoms and disease progression, reducing inflammatory markers and motor neuron death in a G93A mouse model of ALS. Spirulina, an early food source eaten by the Aztecs, may have a combined antioxidant and anti-inflammatory effect on motor neurons, according to the researchers.

The study's findings were published in the 2010, volume 3 issue of the Open Tissue Engineering and Regenerative Medicine Journal. "ALS is a degenerative motor neuron disease,” said the study's lead author, Svitlana Garbuzova-Davis, PhD, DSc, assistant professor in the department of neurosurgery and brain repair at the University of South Florida (USF; Tampa, USA). "Most available treatments relieve symptoms without altering the underlying disease. However, evidence for oxidative stress has been associated with ALS, and in our past studies, we demonstrated potent decreases in markers of oxidative damage and inflammation in aged rats fed diets supplemented with Spirulina or spinach. In this initial study, the diet supplement was fed only to presymptomatic mice. Further studies showing the diet supplement's effect on the lifespan of symptomatic ALS mice are needed to prove the treatment's effectiveness.”

Specifically, when the USF researchers tested compounds found in blueberries and Spirulina for effectiveness in animal models of stroke and aging in earlier research, they noted neuroprotective effects of the nutritional supplements.

The current study compared ALS mice receiving a Spirulina-supplemented diet over a 10-week period with mice that did not receive the diet supplementation. The Spirulina-fed ALS mice showed reduced inflammatory markers and motor neuron degeneration over that period.

"The focus of our future ALS experiments will include motor neuron counts and an examination of lifespan following dietary Spirulina supplementation in symptomatic ALS mice,” said study coauthor Paula C. Bickford, PhD, a professor in the USF department of neurosurgery and Brain Repair and a senior research biologist at the James A. Haley Veterans' Hospital (Tampa, FL, USA).

Related Links:
University of South Florida


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Verification Panels for Assay Development & QC
Seroconversion Panels
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
Pipette Controller
Sapphire MaxiPette
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.